« Back
Home /
Regorafenib

Regorafenib

Item no.	M1669-50mg
Manufacturer	AbMole
CASRN	755037-03-7
Amount	50mg
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Brain Cancer
Type	Inhibitors
Specific against	other
Purity	0,9823
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	BAY 73-4506
Similar products	Regorafenib, BAY 73-4506
Available
Target Information	VEGFR/PDGFR
Molecular Weight	482, 82
Solubility	DMSO ≥ 100 mg/mL
Bioactivity information	Regorafenib (BAY 73-4506) is a novel oral multikinase inhibitor of c-KIT, VEGFR2, B-Raf with IC50s of 17, 40 and 69 nM respectively.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M1669-50mg-safety-datasheet.pdf